Navigation Links
Live Webinar on Protection of Phase 1 Research Volunteers
Date:1/10/2013

Toronto, Canada (PRWEB) January 10, 2013

Join esteemed speakers, Dr. Agnes Klein, MD, MPH, Director, Centre for the Evaluation of Radiopharmaceuticals and Biotherapeutic Products in the Biologics and Genetic Therapies Directorate, Health Canada, and Dr. Richard Larouche, BPharm, MD, Director, Medical Affairs, Early Stage Development, Pharmanet/i3, as they examine the current risks and approaches.

The outbreak of new infectious diseases on a global scale such as SARS, swine flu (H1N1), avian flu (H1N5), received wide press coverage and caused panic in the general population. As of November 30, 2012, there were nine confirmed cases of a SARS-like illness in the Middle East, five of which were fatal. When the next pandemic is due is unknown, but it is only a matter of time before the next pandemic is a reality. Simultaneously, infectious diseases such as TB, polio, rubella, pertussis, etc., are on the rise in developing countries as well as the West.

Phase 1 research typically involves confinement of volunteers in a group living setting, sometimes for extended periods, thus putting them at risk of exposure to communicable disease carried by fellow subjects or clinic staff. First-in-humans research with compounds targeting the immune system, or special populations such as the elderly or those with renal or hepatic impairment, represent even greater potential risks.

Dr. Klein will discuss Health Canada’s approach and requirements. Dr. Larouche will discuss the practical dimensions of the problem, and what must be done at the clinic level, over and above regulatory requirements.

For more information or to register go to http://xtks.in/xto552irb.

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global Life Sciences community. Every year thousands of industry practitioners turn to
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Northeastern University Nanomanufacturing Center Director Ahmed Busnaina to Present Webinar on “The Democratization of Manufacturing”
2. Webinar Announcement: GenomeSpace: A New Solution for Integrating Genomic Analysis Tools
3. Best Practices, LLC Issues New Report and Webinar on Managing Healthcare Reform through Effective Engagement with the Government Ecosystem
4. BioPharm Systems to Host Webinar on Self-service Account Management for Oracle Clinical, Remote Data Capture, and Thesaurus Management System
5. The Veterinary Bioscience Institute Announces an Amazing Series of 41 Webinars for 2013
6. The Veterinary Bioscience Institute Announces its January 2013 Webinar Schedule
7. Webinar on Clinical, Regulatory and Commercialization Strategies for Rare Diseases
8. Ampio Pharmaceuticals Awarded Canadian Composition of Matter Patent That Strengthens IP Protection for Its Key Drug Ampion™
9. Luminex Corporation to Speak at Joint Department of Defense and Environmental Protection Agency 5th National Bio-Threat Conference
10. Islet Sciences Announces DiaKine Therapeutics Novel Diabetes, Atherosclerosis Drugs Receives European Patent Protection
11. Biotechnology and Environmental Protection at this Years ACHEMA
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... , June 18, 2013 ... international investment research firm, announces the initiation ... a French biopharmaceutical company developing and marketing ... care indications.      (Logo: http://photos.prnewswire.com/prnh/20130417/608168) ... comprehensive report examining the investment merits of ...
(Date:6/18/2013)... 2013  Techne Corporation (NASDAQ: TECH ... to acquire 100% ownership of Bionostics Holdings Limited ... is a global leader in the development, manufacture ... proper operation of in vitro diagnostic ... blood glucose and blood gas testing.  Biosnostics has ...
(Date:6/18/2013)... , June 18, 2013   Lexicon ... a biopharmaceutical company focused on discovering breakthrough treatments ... Northcott has joined the company as its ... Mr. Northcott brings extensive commercial experience to Lexicon, ... a variety of therapeutic areas. Mr. ...
(Date:6/18/2013)... (PRWEB) June 18, 2013 Inflamax ... Proof of Concept and Phase I-IV clinical trials, ... alliance with Northern Air Environmental Technologies (NAET), a ... the deployment, monitoring, and servicing of mobile Environmental ... Ocular clinical trials. , Inflamax ...
Breaking Biology Technology:Edison Expands French Healthcare Sector Coverage With Initiation of Coverage on BioAlliance Pharma 2Edison Expands French Healthcare Sector Coverage With Initiation of Coverage on BioAlliance Pharma 3Techne Corporation Announces Acquisition Agreement 2Techne Corporation Announces Acquisition Agreement 3Techne Corporation Announces Acquisition Agreement 4Techne Corporation Announces Acquisition Agreement 5John Northcott Joins Lexicon as Vice President of Marketing, Commercial Strategy and Operations 2John Northcott Joins Lexicon as Vice President of Marketing, Commercial Strategy and Operations 3Inflamax Research Inc. Enters Strategic Partnership with Northern Air Environmental Technologies Inc. 2Inflamax Research Inc. Enters Strategic Partnership with Northern Air Environmental Technologies Inc. 3
... CLAREMONT, Calif., Oct. 25, 2011 Keck Graduate Institute (KGI) ... speaker at the upcoming Pichia 2012 conference from February 23 ... spent years conducting internationally-renowned research on the development and use ... system for the production of recombinant proteins. At ...
... JUNCTION, N.J., Oct. 25, 2011 Insmed Incorporated (Nasdaq CM: ... Tuesday, November 8 th , 2011, at 8:30 AM ET, ... 2011.  Insmed intends to issue its quarterly financial results press ... To participate in the live conference call, ...
... Amsterdam Molecular Therapeutics (Euronext: AMT), a leader in the ... on operations and disclosed the outcome of a strategic ... management and AMT,s Board of Directors that enables the ... development. The CHMP,s recent opinion, while not approving Glybera®, ...
Cached Biology Technology:KGI Professor Cregg to Be Featured Speaker at Pichia 2012 Conference 2Insmed to Host 2011 Third Quarter Earnings Conference Call 2Insmed to Host 2011 Third Quarter Earnings Conference Call 3Amsterdam Molecular Therapeutics Provides Operations Update & Strategic Review of Pipeline 2Amsterdam Molecular Therapeutics Provides Operations Update & Strategic Review of Pipeline 3Amsterdam Molecular Therapeutics Provides Operations Update & Strategic Review of Pipeline 4
(Date:6/17/2013)... Biochemical and Biophysical Research Communications , Saint Louis ... previously unknown viruses. The technique offers the potential to ... identified a particular virus as the likely source of ... scientists use blood serum as a biological source to ... complete deciphering of the human genome, SLU researchers used ...
(Date:6/17/2013)... bacteria, and algae, is a common component of sugar-free ... the medical field it,s approved by the FDA ... used during surgery as a substance that opens the ... , Now Profs. Ehud Gazit and Daniel Segal of ... and the Sagol School of Neuroscience, along with their ...
(Date:6/17/2013)... CORVALLIS, Ore. Amphibian populations are declining worldwide and ... be spread by bullfrogs, but a two-year study shows ... suggestions that bullfrogs are a tolerant carrier host that ... frogs from eggs in controlled experimental conditions, they found ... dendrobatidis , also called Bd or a chytrid fungus, ...
Breaking Biology News(10 mins):Saint Louis University researchers discover a way to detect new viruses 2Saint Louis University researchers discover a way to detect new viruses 3Artificial sweetener a potential treatment for Parkinson's disease 2Bullfrogs may help spread deadly amphibian fungus, but also die from it 2
... International Scientific Congress attended by more than 2,500 delegates ... The conclusions will be published as a full report ... the Danish Prime Minister Mr. Anders Fogh Rasmussen today. ... Conference in December 2009 and will hand over the ...
... have taken a first look at the broad genetic ... Although scientists have known for more than a century ... are likely to suffer from low reproductive success, the ... still the subject of debate. The new study, ...
... An international research team, involving Professor Rajeev Ahuja at ... to understand the mechanism behind the catalytic effects of ... a synergistic approach and the results, published this week ... Letters , will fasten efforts to develop new catalysts. ...
Cached Biology News:'Climate change: Global risks, challenges and decisions' 2'Climate change: Global risks, challenges and decisions' 3Researchers take first look at the genetic dynamics of inbreeding depression 2Researchers take first look at the genetic dynamics of inbreeding depression 3Revealing new applications for carbon nanomaterials in hydrogen storage 2
... The Jouan RC Sensitive Bio (for heat-labile ... evaporator systems respond to specific applications of ... safe concentration of heat-labile samples. The RC ... of cold traps and a wide selection ...
... The KingFisher magnetic particle based purification ... and DNA/RNA from any sample. They offer ... family comprises three systems- KingFisher, KingFisher mL ... 20 - 1000 l. Each system consists ...
... set the standard for centrifugal concentration and drying. ... of centrifugal force, heat and vacuum to dry ... equipped with:, , TEFLON-coated Rotor Chamber ... , Three Selectable Heating Levels ...
... (for aqueous, other low volatility and noxious ... to specific applications of molecular biology and ... heat-labile samples. The RC systems can be ... and a wide selection of rotors (eliminating ...
Biology Products: